Anzeige
Mehr »
Login
Montag, 13.01.2025 Börsentäglich über 12.000 News von 681 internationalen Medien
Die 1 Billionen Dollar Mine: Power Nickels Weg zur globalen Dominanz!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
GlobeNewswire (Europe)
500 Leser
Artikel bewerten:
(2)

FUJIFILM Holdings America Corporation: FUJIFILM VisualSonics and PIUR IMAGING Partner to Enable Ultra-High Frequency, 3D Ultrasound Imaging Technology

Finanznachrichten News

Toronto & Vienna, Feb. 10, 2022, a global provider of ultra-high-frequency, the European leader in tomographic ultrasound imaging, have partnered to bring UHF, three-dimensional (3D) ultrasound imaging technology to clinicians and researchers. This technological advancement supports clinical research in the evaluation of anomalies in several applications, including dermatology, neurology, vascular, and MSK.

"UHF ultrasound, delivered through FUJIFILM VisualSonics' systems, is the highest resolution medical ultrasound available today. The FUJIFILM VisualSonics' Vevo MD, coupled with PIUR IMAGING's tUS Infinity platform, offers researchers and clinicians the ability to visualize and measure ultrasound volumes in 3D," said Greg Nesbitt, vice president, global high frequency, FUJIFILM VisualSonics. "We are confident that our partnership with PIUR IMAGING will enable users to add a new dimension in visualizing pathological tissue in a variety of clinical applications."

PIUR tUS Infinityis a wireless add-on solution, consisting of a patented sensor-based tracking unit, a video transmission box, and software for image analysis and 3D rendering. When combined with FUJIFILM VisualSonics' Vevo MD ultrasound imaging system, this produces three-dimensional UHF ultrasound volumetrics.

The Infinity sensor, when clipped onto a FUJIFILM VisualSonics' Vevo MD ultrasound transducer, works seamlessly with the workstation running the Infinity software. It collects information from the video box and sensor and applies AI-based image reconstruction algorithms to generate tomographic ultrasound volumes with smart analysis tools to efficiently extract diagnostic information.

With this technology, users can now:

  • Combine 3D imaging with clinical UHF ultrasound
  • Collect fast, easy 3D images of anatomy of interest (vessels, nerves, lymphatics etc.)
  • Speed up analysis with automatic segmentation
  • Calculate length, area and volume with ease

"Our company's mission is to bridge the gap between ultrasound, as a safe and cost effective 2D imaging solution, and three-dimensional imaging technologies like CT and MR. With PIUR tUS Infinity, we can offer the best of both worlds and generate 3D diagnostic information without the need to refer patients outside the ultrasound lab.", says Robert Bauer, CTO of PIUR IMAGING. "The combination of FUJIFILM VisualSonics and PIUR IMAGING technologies creates the industry's first handheld, UHF, 3D ultrasound imaging technology. Together, the combined technologies are designed to streamline clinicians' and researchers' workflow by separating ultrasound acquisition from image analysis."

Clinicians and researchers today can purchase PIUR IMAGING's PIUR tUS Infinity system as an add-on to the FUJIFILM VisualSonics Vevo MD UHF ultrasound system in Europe. The PIUR Infinity System is the subject of a pending 510(k), and is not available for sale within the United States. The PIUR Infinity System is the subject of a pending medical device license application, and is not available for sale within Canada.

Click hereto learn more about the Vevo MD / PIUR tUS Infinity technology combination.

About Fujifilm VisualSonics

FUJIFILM VisualSonics, Inc., is a global leader in real time, in vivo, ultra-high frequency ultrasound and photoacoustic imaging systems. With headquarters in Toronto, Canada and offices around the world, FUJIFILM VisualSonics is represented globally across an integrated sales network. FUJIFILM VisualSonics is recognized worldwide for providing cutting edge imaging technologies for the advancement of preclinical research, particularly in cardiovascular, oncology, neurobiology and developmental biology fields. With the expansion of the product portfolio to include a clinical product, FUJIFILM VisualSonics now broadens their range of imaging solutions across both preclinical and clinical markets. FUJIFILM VisualSonics is a subsidiary of FUJIFILM Sonosite, Inc. and a part of FUJIFILM Holdings Corporation.

FUJIFILM Holdings Corporation, Tokyo, Japan, brings cutting edge solutions to a broad range of global industries by leveraging its depth of knowledge and fundamental technologies developed in its relentless pursuit of innovation. Its proprietary core technologies contribute to various fields including healthcare, highly functional materials, document solutions, and imaging products. These products and services are based on its extensive portfolio of chemical, mechanical, optical, electronic, and imaging technologies. For the year ended March 31, 2021, the company had global revenues of $21 billion, at an exchange rate of 106 yen to the dollar. Fujifilm is committed to responsible environmental stewardship and good corporate citizenship. For more information, please visit: www.fujifilmholdings.com

About PIUR IMAGING GmbH

PIUR imaging GmbH is a medical device company headquartered in Vienna, Austria. Founded in 2014, PIUR's vision is to maximize access to safe and accurate image diagnostics through AI-driven tomographic ultrasound solutions.


© 2022 GlobeNewswire (Europe)
6 Richtige für 2025
Das Börsenjahr 2025 klopft schon an die Tür – und wie immer geht es um die Frage: Welche Aktien werden die großen Gewinner sein? Die Auswahl an Möglichkeiten ist riesig, doch nur ein paar echte Volltreffer stechen heraus.

Ob stabiler Dividenden-Lieferant, Tech-Pionier oder spekulative Wette im Krypto-Bereich – wir haben die Märkte für Sie ausgiebig durchforstet und präsentieren Ihnen 6 Unternehmen, die große Chancen auf außergewöhnliche Kurssteigerungen besitzen. Hier sind, speziell für Sie, Ihre „6 Richtigen“ für 2025.

Fordern Sie jetzt unseren neuen kostenlosen Spezialreport an und erfahren Sie, welche Unternehmen das Potenzial besitzen, im kommenden Jahr richtig durchzustarten!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.